Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

This study has been completed.
Sponsor:
Collaborators:
National Medical University, Ukraine
Immunitor USA Inc.
Information provided by (Responsible Party):
Lisichansk Regional Tuberculosis Dispensary
ClinicalTrials.gov Identifier:
NCT01222338
First received: June 30, 2010
Last updated: August 2, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
No publications provided by Lisichansk Regional Tuberculosis Dispensary

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):